{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:45:01Z","timestamp":1784223901942,"version":"3.55.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T00:00:00Z","timestamp":1650153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.phymed.2022.154103","type":"journal-article","created":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T09:28:46Z","timestamp":1650187726000},"page":"154103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4282-5740","authenticated-orcid":false,"given":"Xiaosheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingxia","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2022.154103_bib0001","unstructured":"AIDS and Hepatitis C Professional Group, S.o.I.D., Chinese Medical Association; Chinese Center for Disease Control and Prevention, 2018. [Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2018)]. Zhonghua Nei Ke Za Zhi 57, 867-884."},{"key":"10.1016\/j.phymed.2022.154103_bib0002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/hiv.09.8","article-title":"Type I interferon in HIV treatment: from antiviral drug to therapeutic target","volume":"3","author":"Boasso","year":"2009","journal-title":"HIV Ther."},{"key":"10.1016\/j.phymed.2022.154103_bib0003","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood.V94.12.4202","article-title":"Constitutive activation of STATs upon in vivo human immunodeficiency virus infection","volume":"94","author":"Bovolenta","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2022.154103_bib0004","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.169.8.4443","article-title":"Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1","volume":"169","author":"Bovolenta","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2022.154103_bib0005","doi-asserted-by":"crossref","first-page":"D36","DOI":"10.1093\/nar\/gku1055","article-title":"Gene: a gene-centered information resource at NCBI","volume":"43","author":"Brown","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0006","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1128\/JVI.00472-06","article-title":"Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy","volume":"80","author":"Cervasi","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.phymed.2022.154103_bib0007","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2007-05-091207","article-title":"STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier","volume":"111","author":"Chaudhuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2022.154103_bib0008","doi-asserted-by":"crossref","first-page":"e15939","DOI":"10.1371\/journal.pone.0015939","article-title":"TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2022.154103_bib0009","first-page":"1169","article-title":"Influence of tripterygium glycosides combined with antiretroviral therapy on CD4\u00a0+\u00a0T cell count in patients with aids poor immune response","volume":"25","author":"Jianren","year":"2018","journal-title":"Clin. Med. Eng."},{"key":"10.1016\/j.phymed.2022.154103_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1172\/JCI90745","article-title":"Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs","volume":"127","author":"Cheng","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phymed.2022.154103_bib0011","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13020-021-00525-z","article-title":"Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity","volume":"16","author":"Cheng","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.phymed.2022.154103_bib0012","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cbic.201100007","article-title":"Triptolide directly inhibits dCTP pyrophosphatase","volume":"12","author":"Corson","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.phymed.2022.154103_bib0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","article-title":"Molecular and transcriptional basis of CD4\u207a T cell dysfunction during chronic infection","volume":"40","author":"Crawford","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2022.154103_bib0014","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/aid.2010.0342","article-title":"HIV-associated immune activation: from bench to bedside","volume":"27","author":"d'Ettorre","year":"2011","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.phymed.2022.154103_bib0015","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2022.154103_bib0016","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0017","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1189\/jlb.69.6.912","article-title":"Functional classification of interferon-stimulated genes identified using microarrays","volume":"69","author":"de Veer","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phymed.2022.154103_bib0018","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/infdis\/jir659","article-title":"CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells","volume":"204","author":"Fernandez","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.phymed.2022.154103_bib0019","first-page":"D87","article-title":"JASPAR 2020: update of the open-access database of transcription factor binding profiles","volume":"48","author":"Fornes","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jneuroim.2006.03.011","article-title":"(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation","volume":"175","author":"Fu","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phymed.2022.154103_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/670957","article-title":"Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions","volume":"2012","author":"Gaardbo","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.phymed.2022.154103_bib0022","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.7150\/thno.57745","article-title":"Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives","volume":"11","author":"Gao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.phymed.2022.154103_bib0023","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ebiom.2018.03.006","article-title":"HIV-1 promotes the degradation of components of the type 1 IFN JAK\/STAT pathway and blocks anti-viral ISG induction","volume":"30","author":"Gargan","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phymed.2022.154103_bib0024","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.molimm.2021.01.030","article-title":"EIF2AK2 selectively regulates the gene transcription in immune response and histones associated with systemic lupus erythematosus","volume":"132","author":"Ge","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.phymed.2022.154103_bib0025","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0026","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/anie.201408817","article-title":"Covalent modification of a cysteine residue in the XPB subunit of the general transcription factor TFIIH through single epoxide cleavage of the transcription inhibitor triptolide","volume":"54","author":"He","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.phymed.2022.154103_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187440","article-title":"Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry","volume":"12","author":"H\u00f8nge","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2022.154103_bib0028","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ptr.3471","article-title":"Triptolide inhibits IFN-\u03b3 signaling via the Jak\/STAT pathway in HaCaT keratinocytes","volume":"25","author":"Hongqin","year":"2011","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0029","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phymed.2022.154103_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5575621","article-title":"Exploring the pharmacological mechanisms of Tripterygium Wilfordii Hook F against cardiovascular disease using network pharmacology and molecular docking","volume":"2021","author":"Huang","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2022.154103_bib0031","doi-asserted-by":"crossref","first-page":"D1117","DOI":"10.1093\/nar\/gkx1028","article-title":"TCMID 2.0: a comprehensive resource for TCM","volume":"46","author":"Huang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0032","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/135965350801300708","article-title":"Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients","volume":"13","author":"Ingiliz","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.phymed.2022.154103_bib0033","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phymed.2022.154103_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/v12040415","article-title":"Tat-based therapies as an adjuvant for an HIV-1 functional cure","volume":"12","author":"Jin","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.phymed.2022.154103_bib0035","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.phymed.2022.154103_bib0036","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3389\/fphar.2020.01194","article-title":"Editorial: network pharmacology and traditional medicine","volume":"11","author":"Lai","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154103_bib0037","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/bioinformatics\/18.8.1135","article-title":"TFBS: computational framework for transcription factor binding site analysis","volume":"18","author":"Lenhard","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.phymed.2022.154103_bib0038","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phymed.2022.154103_bib0039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/QAD.0b013e328340fd61","article-title":"HIV-1 trans-activator protein dysregulates IFN-\u03b3 signaling and contributes to the suppression of autophagy induction","volume":"25","author":"Li","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.phymed.2022.154103_bib0040","first-page":"3448","article-title":"Bioinformatics analysis on immune response pathways of triptolide in treating AIDS","volume":"44","author":"Li","year":"2019","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.phymed.2022.154103_bib0041","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application","volume":"11","author":"Li","year":"2013","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.phymed.2022.154103_bib0042","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1179\/1528433614Z.0000000005","article-title":"Tripterygium Wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety","volume":"16","author":"Li","year":"2015","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.phymed.2022.154103_bib0043","first-page":"158","article-title":"[Effects of triptolide on the production of interferon-gamma in human peripheral blood mononuclear cell and phosphorylation of signal transducer and activator of transcription-1 and production of interleukin-8]","volume":"29","author":"Li","year":"2007","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.phymed.2022.154103_bib0044","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12906-018-2305-7","article-title":"Efficacy and safety of Tripterygium Wilfordii Hook F for chronic urticaria: a systematic review and meta-analysis","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.phymed.2022.154103_bib0045","article-title":"Comparative transcriptional analysis identified characteristic genes and patterns in HIV-infected immunological non-responders","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2022.154103_bib0046","doi-asserted-by":"crossref","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0047","doi-asserted-by":"crossref","first-page":"572","DOI":"10.52586\/4968","article-title":"Current strategies and technologies for finding drug targets of active components from traditional Chinese medicine","volume":"26","author":"Lu","year":"2021","journal-title":"Front. Biosci."},{"key":"10.1016\/j.phymed.2022.154103_bib0048","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.chembiol.2013.12.009","article-title":"TAB1: a target of triptolide in macrophages","volume":"21","author":"Lu","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.phymed.2022.154103_bib0049","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11684-018-0649-5","article-title":"Immunoregulatory effects of Tripterygium Wilfordii Hook F and its extracts in clinical practice","volume":"13","author":"Luo","year":"2019","journal-title":"Front. Med."},{"key":"10.1016\/j.phymed.2022.154103_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2623085","article-title":"Efficacy and safety of Tripterygium Wilfordii Hook F on psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials","volume":"2018","author":"Lv","year":"2018","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.phymed.2022.154103_bib0051","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7316456","article-title":"HIV-related immune activation and inflammation: current understanding and strategies","volume":"2021","author":"Lv","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0052","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1189\/jlb.0403156","article-title":"Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression","volume":"74","author":"Magnani","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phymed.2022.154103_bib0053","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2014.05.030","article-title":"Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study","volume":"61","author":"Miailhes","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2022.154103_bib0054","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-011110-130254","article-title":"Pathogenic mechanisms of HIV disease","volume":"6","author":"Moir","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.phymed.2022.154103_bib0055","first-page":"517","article-title":"Searching the MEDLINE literature database through PubMed: a short guide","volume":"28","author":"Motschall","year":"2005","journal-title":"Onkologie"},{"key":"10.1016\/j.phymed.2022.154103_bib0056","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1186\/s12859-019-3142-5","article-title":"PROMO: an interactive tool for analyzing clinically-labeled multi-omic cancer datasets","volume":"20","author":"Netanely","year":"2019","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.phymed.2022.154103_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007246","article-title":"Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication","volume":"14","author":"Nganou-Makamdop","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.phymed.2022.154103_bib0058","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1753425918803674","article-title":"HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation","volume":"24","author":"Nguyen","year":"2018","journal-title":"Innate Immun."},{"key":"10.1016\/j.phymed.2022.154103_bib0059","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","article-title":"Triptolide and its derivatives as cancer therapies","volume":"40","author":"Noel","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2022.154103_bib0060","first-page":"238","article-title":"Effects of triptonide on mouse immune functions","volume":"14","author":"Pei","year":"1993","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.phymed.2022.154103_bib0061","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.embor.embor802","article-title":"Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons","volume":"4","author":"Pilz","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.phymed.2022.154103_bib0062","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijid.2019.02.016","article-title":"Epidemiological analyses of regional and age differences of HIV\/AIDS prevalence in China, 2004-2016","volume":"81","author":"Qiao","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.phymed.2022.154103_bib0063","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/COH.0000000000000231","article-title":"Immune activation and paediatric HIV-1 disease outcome","volume":"11","author":"Roider","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.phymed.2022.154103_bib0064","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminform."},{"key":"10.1016\/j.phymed.2022.154103_bib0065","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1074\/jbc.R116.774562","article-title":"The molecular basis for differential type I interferon signaling","volume":"292","author":"Schreiber","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2022.154103_bib0066","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/COH.0000000000000244","article-title":"Immune activation and HIV: an enduring relationship","volume":"11","author":"Sereti","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.phymed.2022.154103_bib0067","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4161\/cbt.8.21.9803","article-title":"Triptolide: an inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells","volume":"8","author":"Soundararajan","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phymed.2022.154103_bib0068","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153046","article-title":"IFN\u03b1-blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health","author":"Swainson","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.phymed.2022.154103_bib0069","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0070","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/aps.2012.108","article-title":"Immunosuppressant discovery from Tripterygium Wilfordii Hook F: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8)","volume":"33","author":"Tang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2022.154103_bib0071","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","article-title":"CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks","volume":"127","author":"Tang","year":"2015","journal-title":"Biosystems"},{"key":"10.1016\/j.phymed.2022.154103_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.583171","article-title":"Tripterygium ingredients for pathogenicity cells in rheumatoid arthritis","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154103_bib0073","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.51470\/PLANTARCHIVES.2021.v21.S1.357","article-title":"A systematic analysis on a potential anti-inflammatory and immunosuppressant herb Tripterygium Wilfordii for the management of rheumatoid arthritis","volume":"21","author":"Tenzin","year":"2021","journal-title":"Plant Arch."},{"key":"10.1016\/j.phymed.2022.154103_bib0074","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.phymed.2022.154103_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COH.0000000000000242","article-title":"Role of immune activation in progression to AIDS","volume":"11","author":"Utay","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.phymed.2022.154103_bib0076","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: a database of predicted functional associations between proteins","volume":"31","author":"von Mering","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0077","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12977-014-0088-6","article-title":"Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein","volume":"11","author":"Wan","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.phymed.2022.154103_bib0078","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0079","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2421631","article-title":"A network pharmacology-based strategy for unveiling the mechanisms of Tripterygium Wilfordii Hook F against diabetic kidney disease","volume":"2020","author":"Wang","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0080","first-page":"D1031","article-title":"Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0081","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12879-018-3643-2","article-title":"Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-\u03b3: a multicenter observational study","volume":"19","author":"Watanabe","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.phymed.2022.154103_bib0082","series-title":"Proceedings of the Conference on Retroviruses and Opportunistic Infections","article-title":"Function of CD4 recovery and decreasing immune activation of a Chinese herb: twHF","author":"Lu","year":"2018"},{"key":"10.1016\/j.phymed.2022.154103_bib0083","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1440-1681.2007.04740.x","article-title":"Immunochemical characterization of the functional constituents of Tripterygium Wilfordii contributing to its anti-inflammatory property","volume":"35","author":"Wong","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.phymed.2022.154103_bib0084","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","article-title":"Toxicity of triptolide and the molecular mechanisms involved","volume":"90","author":"Xi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2022.154103_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.794962","article-title":"Based on network pharmacology tools to investigate the mechanism of Tripterygium Wilfordii against IgA nephropathy","volume":"8","author":"Xia","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.phymed.2022.154103_bib0086","series-title":"RSC Adv.","first-page":"34572","article-title":"Computational prediction and experimental validation of low-affinity target of triptolide and its analogues","author":"Liu","year":"2015"},{"key":"10.1016\/j.phymed.2022.154103_bib0087","doi-asserted-by":"crossref","first-page":"D976","DOI":"10.1093\/nar\/gky987","article-title":"ETCM: an encyclopaedia of traditional Chinese medicine","volume":"47","author":"Xu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2022.154103_bib0088","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","article-title":"Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: challenges of immunological non-responders","volume":"107","author":"Yang","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phymed.2022.154103_bib0089","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","article-title":"TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models","volume":"30","author":"Yao","year":"2016","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.phymed.2022.154103_bib0090","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1535-7163.MCT-15-0753","article-title":"Triptolide induces cell killing in multidrug-resistant tumor cells via CDK7\/RPB1 rather than XPB or p44","volume":"15","author":"Yi","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phymed.2022.154103_bib0091","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ebiom.2018.09.031","article-title":"Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-\u03baB and improving mitochondrial function","volume":"36","author":"Yu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phymed.2022.154103_bib0092","first-page":"748","article-title":"Effect of Tripterygium Wilfordii treatment on CD4\u00a0+\u00a0T lymphocyte and inflammatory factors in AIDS patients","volume":"33","author":"Zhang","year":"2018","journal-title":"J. N. Sichuan Med. Coll."},{"key":"10.1016\/j.phymed.2022.154103_bib0093","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/med.21762","article-title":"Tripterygium Wilfordii: an inspiring resource for rheumatoid arthritis treatment","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phymed.2022.154103_bib0094","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1172\/JCI89488","article-title":"Targeting type I interferon-mediated activation restores immune function in chronic HIV infection","volume":"127","author":"Zhen","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phymed.2022.154103_bib0095","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2018.00356","article-title":"The effectiveness and safety of Tripterygium Wilfordii Hook F extracts in rheumatoid arthritis: a systematic review and meta-analysis","volume":"9","author":"Zhou","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2022.154103_bib0096","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13075-018-1563-6","article-title":"Comparison of the impact of Tripterygium Wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study","volume":"20","author":"Zhou","year":"2018","journal-title":"Arthritis Res. Ther."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:34:42Z","timestamp":1760553282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711322001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":96,"alternative-id":["S0944711322001817"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154103","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154103"}}